NCT02215824View on ClinicalTrials.gov

Investigation of Safety, Pharmacokinetics and Pharmacodynamics of Different Doses of BIWH 3 in Patients With Chronic Critical Limb Ischaemia

PHASE1TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

October 31, 2003

Conditions
Peripheral Arterial Disease
Interventions
DRUG

BIWH 3

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY